Literature DB >> 17067311

Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators.

Anja K Schröder1, Maren von der Ohe, Ute Kolling, Julia Altstaedt, Peter Uciechowski, Daniela Fleischer, Klaus Dalhoff, Xinsheng Ju, Martin Zenke, Nicole Heussen, Lothar Rink.   

Abstract

The role of neutrophils in the immune response has long been regarded as mainly phagocytic, but recent publications have indicated the production of several cytokines by polymorphonuclear leucocytes (PMN). The results of the individual reports, however, vary considerably. In this study, we established a cytokine profile of pure human neutrophils and demonstrated that minor contamination of peripheral blood mononuclear cells (PBMCs) in PMN preparations can lead to false-positive results. In our hands, peripheral blood PMN fail to produce the pro-inflammatory cytokines interleukin (IL)-1beta, IL-6 and tumour necrosis factor-alpha (TNF-alpha). Instead, they secrete large amounts of the chemokine IL-8 and the anti-inflammatory IL-1 receptor antagonist (IL-1ra). Additionally, PMN preparations of a high purity show production of the chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and growth-related oncogene-alpha (GRO-alpha), as well as macrophage colony-stimulating factor (M-CSF). The neutrophil therefore represents a novelty by producing the antagonist of IL-1beta (i.e. IL-1ra) in the absence of IL-1beta itself. To support our results, we differentiated stem cells from human cord blood into PMN and monocytes, respectively. These in vitro-differentiated PMN showed the same cytokine profile as peripheral blood PMN lacking IL-1beta, while differentiated monocytes produced the expected IL-1beta in addition to IL-1ra. The clear anti-inflammatory nature of their cytokine profile enables PMN to antagonize pro-inflammatory signals in experimental conditions. It is therefore possible that PMN play a key role in immune regulation by counteracting a dysregulation of the inflammatory process. Clinical studies, in which administration of recombinant G-CSF had a favourable effect on the outcome of severe infections and even sepsis without worsening inflammation, could thus be explained by our results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067311      PMCID: PMC1819575          DOI: 10.1111/j.1365-2567.2006.02435.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  61 in total

1.  Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection.

Authors:  L Grigull; A Schrauder; A Schmitt-Thomssen; K Sykora; K Welte
Journal:  Infection       Date:  2002-10       Impact factor: 3.553

2.  Differentiation of human antigen-presenting dendritic cells from CD34+ hematopoietic stem cells in vitro.

Authors:  Xin-Sheng Ju; Martin Zenke
Journal:  Methods Mol Biol       Date:  2003

Review 3.  Primary inherited defects in neutrophil function: etiology and treatment.

Authors:  H L Malech; W M Nauseef
Journal:  Semin Hematol       Date:  1997-10       Impact factor: 3.851

Review 4.  Interleukin-1 receptor antagonist: role in biology.

Authors:  W P Arend; M Malyak; C J Guthridge; C Gabay
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

5.  Human polymorphonuclear leukocytes produce IL-12, TNF-alpha, and the chemokines macrophage-inflammatory protein-1 alpha and -1 beta in response to Toxoplasma gondii antigens.

Authors:  S K Bliss; A J Marshall; Y Zhang; E Y Denkers
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

6.  Membrane proteinase 3 expression in patients with Wegener's granulomatosis and in human hematopoietic stem cell-derived neutrophils.

Authors:  Adrian Schreiber; Bjoern Otto; Xinsheng Ju; Martin Zenke; Ursula Goebel; Friedrich C Luft; Ralph Kettritz
Journal:  J Am Soc Nephrol       Date:  2005-05-18       Impact factor: 10.121

7.  An audit of the use of granulocyte colony-stimulating factor in septic shock.

Authors:  D P Stephens; D A Fisher; B J Currie
Journal:  Intern Med J       Date:  2002-04       Impact factor: 2.048

8.  Neutrophils as firemen, production of anti-inflammatory mediators by neutrophils in a mixed cell environment.

Authors:  Liyu Xing; Daniel G Remick
Journal:  Cell Immunol       Date:  2005-02-10       Impact factor: 4.868

9.  The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes.

Authors:  M Malyak; M F Smith; A A Abel; K R Hance; W P Arend
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

10.  Inhibition of neutrophil apoptosis and modulation of the inflammatory response by granulocyte colony-stimulating factor in healthy and ethanol-treated human volunteers.

Authors:  K Dalhoff; F Hansen; D Drömann; B Schaaf; S P Aries; J Braun
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

View more
  15 in total

1.  Residence in biofilms allows Burkholderia cepacia complex (Bcc) bacteria to evade the antimicrobial activities of neutrophil-like dHL60 cells.

Authors:  Mark P Murphy; Emma Caraher
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

2.  Low-level laser therapy in different stages of rheumatoid arthritis: a histological study.

Authors:  Ana Carolina Araruna Alves; Paulo de Tarso Camillo de Carvalho; Marcio Parente; Murilo Xavier; Lucio Frigo; Flávio Aimbire; Ernesto Cesar Pinto Leal Junior; Regiane Albertini
Journal:  Lasers Med Sci       Date:  2012-04-27       Impact factor: 3.161

3.  Neutrophil depletion delays wound repair in aged mice.

Authors:  Naomi Nishio; Yayoi Okawa; Hidetoshi Sakurai; Ken-ichi Isobe
Journal:  Age (Dordr)       Date:  2008-01-08

4.  In-vivo extravasation induces the expression of interleukin 1 receptor type 1 in human neutrophils.

Authors:  J M Paulsson; A Moshfegh; E Dadfar; C Held; S H Jacobson; J Lundahl
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

5.  Changes in chromatin structure and methylation of the human interleukin-1beta gene during monopoiesis.

Authors:  Inga Wessels; Daniela Fleischer; Lothar Rink; Peter Uciechowski
Journal:  Immunology       Date:  2010-02-05       Impact factor: 7.397

6.  Neonatal neutrophils with prolonged survival secrete mediators associated with chronic inflammation.

Authors:  Caroline N Nguyen; Patricia M Schnulle; Nasser Chegini; Xiaoping Luo; Joyce M Koenig
Journal:  Neonatology       Date:  2010-06-10       Impact factor: 4.035

7.  Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin.

Authors:  Zhifang Zhang; Gregory Cherryholmes; John E Shively
Journal:  J Leukoc Biol       Date:  2008-06-04       Impact factor: 4.962

Review 8.  Induction and termination of inflammatory signaling in group B streptococcal sepsis.

Authors:  Julia Wennekamp; Philipp Henneke
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

Review 9.  Inflammaging and the Lung.

Authors:  Elizabeth J Kovacs; Devin M Boe; Lisbeth A Boule; Brenda J Curtis
Journal:  Clin Geriatr Med       Date:  2017-07-14       Impact factor: 3.076

10.  Infrared low-level diode laser on inflammatory process modulation in mice: pro- and anti-inflammatory cytokines.

Authors:  Thiago Y Fukuda; Maury M Tanji; Suélen R Silva; Maria N Sato; Hélio Plapler
Journal:  Lasers Med Sci       Date:  2012-11-24       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.